Replies to post #245703 on Biotech Values

[DewDiligence]

...potentially underestimates [the hospitalization rate] as the study was in a fairly healthy population overall.

This is a crucial point.

...bodes well for GSK tomorrow.

Based on what occurred today, I would say the panel's endorsement of GSK's vaccine tomorrow is a fait accompli.